Schizoaffective Disorder
📧 Sign up to get email alerts when something new happens for Schizoaffective Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-10-13Clinical Trial Update: A Trial to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 (Asenapine) Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937) [Phase 2]
Phase 2 trial comparing two dosing strengths of Sublingually Org 5222 (asenapine) to assess safety and equivalence in schizophrenia or schiz…
-
CLINICAL_TRIALS trial_result · 2010-08-31Clinical Trial Update: A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With Schizophrenia [Phase 4]
A Phase 4 clinical trial evaluated atomoxetine for negative symptoms in schizophrenia (and schizoaffective disorder); the study has complete…
-
CLINICAL_TRIALS trial_result · 2010-08-16Clinical Trial Update: Reduction of Cardiovascular Risk in Severe Mental Illness [Phase 4]
Phase 4 clinical trial update exploring reduction of cardiovascular risk in individuals with severe mental illness, including schizophrenia …
-
CLINICAL_TRIALS trial_result · 2010-08-10Clinical Trial Update: A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]
Phase 3 trial evaluating relapse prevention using long-acting injectable risperidone and quetiapine tablets in patients with schizophrenia o…
-
CLINICAL_TRIALS trial_result · 2010-08-09Clinical Trial Update: Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness [NA]
Clinical trial update noting the completion and outcome evaluation of the Solutions for Wellness and Team Solutions Program in adults with s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2010-06-29Clinical Trial Update: Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia Patients [Phase 3]
Phase 3 trial evaluating bexarotene and fenretinide as add-on therapy to antipsychotics in schizophrenia and schizoaffective disorder has be…
-
CLINICAL_TRIALS trial_result · 2010-04-27Clinical Trial Update: A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine. [Phase 4]
This Phase 4 study evaluated three strategies for switching patients with schizophrenia or schizoaffective disorder from olanzapine to rispe…
-
CLINICAL_TRIALS trial_result · 2010-04-26Clinical Trial Update: Bioequivalence Study Comparing 2 Formulations for 4 mg Risperidone Tablet. [Phase 1]
A Phase 1 bioequivalence study comparing two formulations of a 4 mg risperidone tablet has completed.
-
FDA approval · 2010-04-15FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Clozapine submitted by Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2010-03-25Clinical Trial Update: An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications. [Phase 4]
This update notes the completion of an open-label Phase 4 trial evaluating metformin for weight control in pediatric patients on antipsychot…
-
CLINICAL_TRIALS trial_result · 2010-03-24Clinical Trial Update: The Effects of Aripiprazole on Patients With Metabolic Syndrome [Phase 4]
Phase 4 trial update assessing the effects of aripiprazole in patients with metabolic syndrome. The study involves conditions including schi…
-
CLINICAL_TRIALS trial_result · 2010-02-02Clinical Trial Update: Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone [Phase 4]
A Phase 4 trial evaluating safety, tolerability, and efficacy of switching from quetiapine to ziprasidone in schizophrenia and schizoaffecti…
-
CLINICAL_TRIALS research · 2010-01-25Clinical Trial Update: A German Multicenter Study on Toxoplasma Gondii in First-episode Schizophrenia
A German multicenter clinical trial investigates the association between Toxoplasma gondii infection and first-episode schizophrenia. The up…
-
CLINICAL_TRIALS trial_result · 2009-12-17Clinical Trial Update: Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS) [Phase 4]
Phase 4 trial APLUS evaluating acute psychosis treatment in a long-term unitary group has completed. The study enrolled patients with schizo…
-
CLINICAL_TRIALS trial_result · 2009-12-16Clinical Trial Update: Health Evaluation of Abilify Long-term Therapy [Phase 4]
Phase 4 clinical trial evaluating long-term Abilify (aripiprazole) therapy for schizophrenia and schizoaffective disorder has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-09Clinical Trial Update: Evaluation of Effectiveness and Safety of Flexible-dose Paliperidone Extended Release in Patients With Schizoaffective Disorder. [Phase 3]
Phase 3 trial evaluating the effectiveness and safety of flexible-dose paliperidone extended-release in patients with schizoaffective disord…
-
CLINICAL_TRIALS trial_result · 2009-11-26Clinical Trial Update: A Comparison of Two Cognitive Batteries in People With Schizophrenia [NA]
This clinical trial record notes the completion of a study comparing two cognitive assessments in individuals with schizophrenia and schizoa…
-
CLINICAL_TRIALS research · 2009-11-26Clinical Trial Update: Study of the Effects of Glycine on Symptoms and Memory in Patients With Schizophrenia [Phase 1]
This Phase 1 clinical trial investigating the effects of glycine on symptoms and memory in schizophrenia and schizoaffective disorder has be…
-
CLINICAL_TRIALS research · 2009-11-19Clinical Trial Update: Identifying Predictors of Response to Antipsychotics Using a Treatment Algorithm [Phase 4]
Phase 4 clinical trial update investigating predictors of response to antipsychotics using a treatment algorithm.
-
CLINICAL_TRIALS trial_result · 2009-09-30Clinical Trial Update: Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine [Phase 3]
Phase 3 study evaluating a therapy to prevent weight gain in patients treated with olanzapine. The trial assessed safety and efficacy, with …
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia [Phase 4]
Phase 4 clinical trial update on early onset antipsychotic drug action in schizophrenia and related disorders; results have been posted.
-
FDA approval · 2009-07-31FDA Approved: INVEGA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for INVEGA (paliperidone) submitted by Janssen Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2009-07-28Clinical Trial Update: Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder. [Phase 3]
Phase 3 clinical trial evaluating the effectiveness and safety of Paliperidone Extended Release in schizoaffective disorder has completed, w…
-
CLINICAL_TRIALS trial_result · 2009-07-23Clinical Trial Update: Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder [Phase 4]
A Phase 4 safety study comparing olanzapine to a comparator in schizophrenia and schizoaffective disorder has completed and results have bee…
-
CLINICAL_TRIALS trial_result · 2009-07-21Clinical Trial Update: Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder [Phase 2]
Phase 2 study evaluating the safety and tolerability of BL-1020 in hospitalized patients with schizophrenia or schizoaffective disorder has …